山东大学教师主页窦蕾 Paper Publications Home

bJp 18H hrc EHj EyQ rL0 kFq MMB 5hQ Ksj OgT NNT V66 QeB of9 D4V Zyy Euk MZm dqS

doulei

+

Personal Information

Gender:Female
Date of Employment:2016-01-06

VIEW MORE

Home > Scientific Research > Paper Publications

[1] 徐艳娇. 基于欧洲五维度五水平健康量表和中文版低视力者生活质量量表测量老年性黄斑变性患者健康相关生命质量. 《中国药物经济学》, 18, 5-9,15, 2023.
[2] 刘世贤. 国内外药物经济学评价研究的文献计量及可视化分析. 《中国医院药学杂志》, 41, 1-10, 2021.
[3] 刘世贤. Cost-effectiveness analysis of nivolumab combination therapy in the first-line treatment for advanced esophageal squamous-cell carcinoma. FRONTIERS IN ONCOLOGY, 12, 899966, 2022.
[4] 刘世贤. 替雷利珠单抗二线治疗晚期或转移性食管鳞状细胞癌的成本-效用分析. 《中国药房》, 33, 2250-2255, 2022.
[5] 王凯旋. 健康效用值在药物经济学评价模型中应用的规范性评价指标体系构建研究. 世界临床药物, 43, 1299-1306, 2022.
[6] . Correlation between disease activity and patient-reported health-related quality of life in rheumatoid arthritis: a cross-sectional study. BMJ Open, 14, 1, 2024.
[7] 刘世贤. Immune checkpoint inhibitors versus chemotherapy as second-line therapy for advanced oesophageal squamous cell carcinoma: a systematic review and economic evaluation. THERAPEUTIC ADVANCES IN GASTROENTEROL..., 17, 2024.
[8] 窦蕾. Health-related quality of life and its changes of the Tibetan population in China based on the 2013 and 2018 National Health Services Surveys. BMJ Open, 13, 1, 2023.
[9] 李超凡. Mapping the Seattle Angina Questionnaire to EQ-5D-5L in patients with coronary heart disease. Health and Quality of Life Outcomes, 21, 2023.
[10] 刘世贤. Cost-effectiveness analysis of PD-1 inhibitors combined with chemotherapy as first-line therapy for advanced esophageal squamous-cell carcinoma in China. FRONT PHARMACOL, 14, 2023.

TOTAL 30 PIECE 1/3

FIRSTPREVIOUSNEXT LAST PAGE